Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data of candidates for prostate cancer active surveillance

ABSTRACT: Expression data of candidates for prostate cancer active surveillance

PROVIDER: PRJNA489796 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

RNAseq of prostate biopsy tissue from prostate cancer patients on active surveillance over 12 months on different diets (ESCAPE trial)

Project description:There is a need to understand genetic and lifestyle factors that may influence the risk of cancer progression in men who have organ-confined prostate cancer and have chosen a programme of 'active surveillance' as opposed to radical treatment with the associated health risks. Epidemiological studies have suggested that consumption of cruciferous vegetables is associated with reduced risk of developing aggressive prostate cancer. In this study we recruited men on active surveillance for low- to intermediate-risk prostate cancer to determine whether a 12-month dietary intervention can elicit transcriptional or nmetabolic responses in their prostate that would be consistent with a reduction in the risk of progression. We undertook RNAseq on prostate biopsies collected before and after a 12-month intervention with broccoli soups.

2020-01-01 | E-MTAB-6525 | biostudies-arrayexpress

Expression data of candidates for prostate cancer active surveillance

Project description:The dataset consists of 266 NCCN very low/low or favorable-intermediate risk PCa patients who underwent diagnostic prostate biopsy between 2000 and 2014 and were treated with RP in six community or academic practices: University of Calgary, Cedars-Sinai, Spectrum Health, Cleveland Clinic, MD Anderson Cancer Center and Johns Hopkins. All patients had complete tumor pathology from biopsy and prostatectomy. Low risk PCa was defined as T1c or cT2a, and Gleason score (GS) ≤ 6, and PSA < 10ng/ml and favorable-intermediate risk was no greater than predominant GS 3 and percent positive biopsy cores < 50%, and either cT2b-cT2c or PSA 10-20ng/ml.

2018-09-08 | GSE119616 | GEO

CIDR: Impact of Genetic Variants on Failure of Active Surveillance for Prostate Cancer

Project description:CIDR: Impact of Genetic Variants on Failure of Active Surveillance for Prostate Cancer

| PRJNA643309 | ENA

CIDR: Impact of Genetic Variants on Failure of Active Surveillance for Prostate Cancer

Project description:CIDR: Impact of Genetic Variants on Failure of Active Surveillance for Prostate Cancer

| PRJNA643310 | ENA

RNAseq of prostate biopsy tissue from prostate cancer patients on active surveillance over 12 months on different diets (ESCAPE trial)

Project description:RNAseq of prostate biopsy tissue from prostate cancer patients on active surveillance over 12 months on different diets (ESCAPE trial)

| PRJEB25542 | ENA

Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancer

Project description:Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancer

| PRJNA933585 | ENA